Observational study on gestational glucose tolerance in women
Toronto Gestational Glucose Tolerance Cohort
This study is looking at pregnant women in their late second trimester to see how their blood sugar levels change during pregnancy and how it might affect their health after giving birth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 350 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | Female |
| Sponsor | Mount Sinai Hospital, Canada Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT02583061 on ClinicalTrials.gov |
What this trial studies
This observational cohort study recruits pregnant women in their late second trimester to assess their glucose tolerance status during pregnancy. Participants represent a range of glucose tolerance, from gestational diabetes to normal levels, and are followed over several years for cardiometabolic characterization. Regular assessments include evaluations of glucose tolerance, beta-cell function, and insulin sensitivity, aiming to understand the development of type 2 diabetes and cardiovascular disease post-pregnancy.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women in their late second trimester.
Not a fit: Patients with pre-existing diabetes before the index pregnancy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the early indicators of type 2 diabetes and cardiovascular disease in women after pregnancy.
How similar studies have performed: Similar observational studies have shown success in understanding the long-term health impacts of gestational diabetes and glucose intolerance.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women Exclusion Criteria: * Pre-existing diabetes before the index pregnancy
Where this trial is running
Toronto, Ontario
- Mount Sinai Hospital — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Ravi Retnakaran, MD — Mount Sinai Hospital
- Study coordinator: Ravi Retnakaran, MD
- Email: ravi.retnakaran@sinaihealth.ca
- Phone: 416-586-4800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.